ULTRASHORT ACTING BETA-BLOCKERS - A PROPOSAL FOR THE TREATMENT OF THE CRITICALLY ILL PATIENT

被引:78
作者
ZAROSLINSKI, J
BORGMAN, RJ
ODONNELL, JP
ANDERSON, WG
ERHARDT, PW
KAM, ST
REYNOLDS, RD
LEE, RJ
GORCZYNSKI, RJ
机构
关键词
D O I
10.1016/0024-3205(82)90547-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:899 / 907
页数:9
相关论文
共 24 条
[1]  
ALHQUIST R, 1977, AM HEART J, V93, P117
[2]  
BLACK JW, 1967, DRUG RESPONSES MAN, P121
[3]   LIMITATION OF MYOCARDIAL INFARCT SIZE BY ATENOLOL, NADOLOL AND PROPRANOLOL IN DOGS [J].
BURMEISTER, WE ;
REYNOLDS, RD ;
LEE, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 75 (01) :7-10
[4]  
CAIRNS JA, 1975, CIRCULATION, V52, P107
[5]   EARLY PHASE OF ACUTE MYOCARDIAL-INFARCTION - PHARMACOLOGIC ASPECTS OF THERAPY [J].
EPSTEIN, SE ;
GOLDSTEIN, RE ;
REDWOOD, DR ;
KENT, KM ;
SMITH, ER .
ANNALS OF INTERNAL MEDICINE, 1973, 78 (06) :918-936
[6]   EFFECT OF BETA-ADRENORECEPTIVE ANTAGONISTS ON MORBIDITY AND MORTALITY IN CARDIOVASCULAR-DISEASE [J].
FITZ GERALD, JD .
POSTGRADUATE MEDICAL JOURNAL, 1976, 52 (614) :770-781
[7]  
FITZ GERALD JD, 1969, CLIN PHARMACOL THER, V10, P292
[8]   CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .3. COMPARATIVE CLINICAL-EXPERIENCE AND NEW THERAPEUTIC APPLICATIONS [J].
FRISHMAN, W ;
SILVERMAN, R .
AMERICAN HEART JOURNAL, 1979, 98 (01) :119-131
[9]   CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .4. ADVERSE-EFFECTS - CHOOSING A BETA-ADRENORECEPTOR BLOCKER [J].
FRISHMAN, W ;
SILVERMAN, R ;
STROM, J ;
ELKAYAM, U ;
SONNENBLICK, E .
AMERICAN HEART JOURNAL, 1979, 98 (02) :256-262